178 related articles for article (PubMed ID: 25882357)
1. Prediction of virological response by pretreatment hepatitis B virus reverse transcriptase quasispecies heterogeneity: the advantage of using next-generation sequencing.
Han Y; Gong L; Sheng J; Liu F; Li XH; Chen L; Yu DM; Gong QM; Hao P; Zhang XX
Clin Microbiol Infect; 2015 Aug; 21(8):797.e1-8. PubMed ID: 25882357
[TBL] [Abstract][Full Text] [Related]
2. Evolutionary patterns of hepatitis B virus quasispecies under different selective pressures: correlation with antiviral efficacy.
Liu F; Chen L; Yu DM; Deng L; Chen R; Jiang Y; Chen L; Huang SY; Yu JL; Gong QM; Zhang XX
Gut; 2011 Sep; 60(9):1269-77. PubMed ID: 21292683
[TBL] [Abstract][Full Text] [Related]
3. Dynamics of hepatitis B virus quasispecies heterogeneity and virologic response in patients receiving low-to-moderate genetic barrier nucleoside analogs.
Peveling-Oberhag J; Herrmann E; Kronenberger B; Farnik H; Susser S; Sarrazin C; Zeuzem S; Hofmann WP
J Viral Hepat; 2013 Apr; 20(4):234-9. PubMed ID: 23490367
[TBL] [Abstract][Full Text] [Related]
4. Comparison of next-generation sequencing and clone-based sequencing in analysis of hepatitis B virus reverse transcriptase quasispecies heterogeneity.
Gong L; Han Y; Chen L; Liu F; Hao P; Sheng J; Li XH; Yu DM; Gong QM; Tian F; Guo XK; Zhang XX
J Clin Microbiol; 2013 Dec; 51(12):4087-94. PubMed ID: 24088859
[TBL] [Abstract][Full Text] [Related]
5. Increased intrahepatic quasispecies heterogeneity correlates with off-treatment sustained response to nucleos(t)ide analogues in e antigen-positive chronic hepatitis B patients.
Chen L; Gan QR; Zhang DQ; Yao LF; Lin RS; Li Q; Lin MH; Yu DM; Zhang XX; Pan C
Clin Microbiol Infect; 2016 Feb; 22(2):201-207. PubMed ID: 26493847
[TBL] [Abstract][Full Text] [Related]
6. Different Variants in Reverse Transcriptase Domain Determined by Ultra-deep Sequencing in Treatment-naïve and Treated Indonesian Patients Infected with Hepatitis B Virus.
Wasityastuti W; Yano Y; Widasari DI; Yamani LN; Ratnasari N; Heriyanto DS; Okada R; Tanahashi T; Murakami Y; Azuma T; Hayashi Y
Kobe J Med Sci; 2016 Jun; 62(1):E1-8. PubMed ID: 27492206
[TBL] [Abstract][Full Text] [Related]
7. Characterization and Clinical Significance of Natural Variability in Hepatitis B Virus Reverse Transcriptase in Treatment-Naive Chinese Patients by Sanger Sequencing and Next-Generation Sequencing.
Fu Y; Zeng Y; Chen T; Chen H; Lin N; Lin J; Liu X; Huang E; Wu S; Wu S; Xu S; Wang L; Ou Q
J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31189581
[TBL] [Abstract][Full Text] [Related]
8. Similar evolution of hepatitis B virus quasispecies in patients with incomplete adefovir response receiving tenofovir/emtricitabine combination or tenofovir monotherapy.
Lavocat F; Dény P; Pichoud C; Al Hawajri N; Kitrinos K; Borroto-Esoda K; Zoulim F
J Hepatol; 2013 Oct; 59(4):684-95. PubMed ID: 23742912
[TBL] [Abstract][Full Text] [Related]
9. Early changes of hepatitis B virus quasispecies during lamivudine treatment and the correlation with antiviral efficacy.
Chen L; Zhang Q; Yu DM; Wan MB; Zhang XX
J Hepatol; 2009 May; 50(5):895-905. PubMed ID: 19304333
[TBL] [Abstract][Full Text] [Related]
10. Effect of hepatitis B virus reverse transcriptase variations on entecavir treatment response.
Wong DK; Kopaniszen M; Omagari K; Tanaka Y; Fong DY; Seto WK; Fung J; Huang FY; Zhang AY; Hung IF; Lai CL; Yuen MF
J Infect Dis; 2014 Sep; 210(5):701-7. PubMed ID: 24610871
[TBL] [Abstract][Full Text] [Related]
11. Complexity and diversity of hepatitis B virus quasispecies: correlation with long-term entecavir antiviral efficacy.
Tong J; Li QL; Huang AL; Guo JJ
Antiviral Res; 2013 Sep; 99(3):312-7. PubMed ID: 23832087
[TBL] [Abstract][Full Text] [Related]
12. Variability of reverse transcriptase and overlapping S gene in hepatitis B virus isolates from untreated and lamivudine-resistant chronic hepatitis B patients.
Pollicino T; Isgrò G; Di Stefano R; Ferraro D; Maimone S; Brancatelli S; Squadrito G; Di Marco V; Craxì A; Raimondo G
Antivir Ther; 2009; 14(5):649-54. PubMed ID: 19704167
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Serum Hepatitis B Virus RNA Levels and Quasispecies Evolution Patterns between Entecavir and Pegylated-Interferon Mono-treatment in Chronic Hepatitis B Patients.
Yu XQ; Wang MJ; Yu DM; Chen PZ; Zhu MY; Huang W; Han Y; Gong QM; Zhang XX
J Clin Microbiol; 2020 Aug; 58(9):. PubMed ID: 32554476
[TBL] [Abstract][Full Text] [Related]
14. Association between lamivudine sensitivity and the number of substitutions in the reverse transcriptase region of the hepatitis B virus polymerase.
Fukai K; Zhang KY; Imazeki F; Kurihara T; Mikata R; Yokosuka O
J Viral Hepat; 2007 Sep; 14(9):661-6. PubMed ID: 17697019
[TBL] [Abstract][Full Text] [Related]
15. Dynamics of hepatitis B virus resistance substitutions correlates with virological response in lamivudine-refractory patients with entecavir rescue monotherapy.
Zhang Y; He S; Li QL; Guo JJ
Virus Res; 2013 Nov; 177(2):156-62. PubMed ID: 23968804
[TBL] [Abstract][Full Text] [Related]
16. A comparative study on the characterization of hepatitis B virus quasispecies by clone-based sequencing and third-generation sequencing.
Li J; Wang M; Yu D; Han Y; Yang Z; Wang L; Zhang X; Liu F
Emerg Microbes Infect; 2017 Nov; 6(11):e100. PubMed ID: 29116219
[TBL] [Abstract][Full Text] [Related]
17. Composition and Interactions of Hepatitis B Virus Quasispecies Defined the Virological Response During Telbivudine Therapy.
Zhou B; Dong H; He Y; Sun J; Jin W; Xie Q; Fan R; Wang M; Li R; Chen Y; Xie S; Shen Y; Huang X; Wang S; Lu F; Jia J; Zhuang H; Locarnini S; Zhao GP; Jin L; Hou J
Sci Rep; 2015 Nov; 5():17123. PubMed ID: 26599443
[TBL] [Abstract][Full Text] [Related]
18. HBV quasispecies composition in Lamivudine-failed chronic hepatitis B patients and its influence on virological response to Tenofovir-based rescue therapy.
Banerjee P; Chakraborty A; Mondal RK; Khatun M; Datta S; Das K; Pandit P; Mukherjee S; Banerjee S; Ghosh S; Chakrabarti S; Chowdhury A; Datta S
Sci Rep; 2017 Mar; 7():44742. PubMed ID: 28303969
[TBL] [Abstract][Full Text] [Related]
19. Response to potent anti-HBV agents in chronic hepatitis B and combined effect of HBV reverse transcriptase mutations.
Singla B; Bhattacharyya R; Chakraborti A; Sharma BK; Kapil S; Chawla YK; Arora SK; Das A; Dhiman RK; Duseja A
Gene; 2015 Aug; 567(1):22-30. PubMed ID: 25917965
[TBL] [Abstract][Full Text] [Related]
20. Mutations associated with lamivudine-resistance in therapy-naïve hepatitis B virus (HBV) infected patients with and without HIV co-infection: implications for antiretroviral therapy in HBV and HIV co-infected South African patients.
Selabe SG; Lukhwareni A; Song E; Leeuw YG; Burnett RJ; Mphahlele MJ
J Med Virol; 2007 Nov; 79(11):1650-4. PubMed ID: 17854040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
